Get started
Emmaus Life Sciences, Inc.Emmaus Life Sciences, Inc.Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

EMMA chart

Key stats

Market capitalization
‪6.30 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0923USD
Net income
‪−10.63 M‬USD
Revenue
‪18.39 M‬USD
Shares float
‪25.36 M‬
Beta (1Y)
0.43

About Emmaus Life Sciences, Inc.

Sector
Health Technology
Headquarters
Torrance
Employees (FY)
55
Website
emmausmedical.com
Founded
1987
ISIN
US29137T1016
FIGI
BBG000BQC327
Emmaus Life Sciences, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EMMA is 0.0921 USD — it has decreased by 19.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Emmaus Life Sciences, Inc. stocks are traded under the ticker EMMA.
Emmaus Life Sciences, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
EMMA stock is 23.50% volatile and has beta coefficient of 0.43. Check out the list of the most volatile stocks — is Emmaus Life Sciences, Inc. there?
EMMA earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.03 USD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Emmaus Life Sciences, Inc. earnings.
Emmaus Life Sciences, Inc. revenue for the last quarter amounts to ‪10.76 M‬ USD despite the estimated figure of ‪5.00 M‬ USD. In the next quarter revenue is expected to reach ‪5.00 M‬ USD.
Yes, you can track Emmaus Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
EMMA stock has fallen by 19.03% compared to the previous week, the month change is a 2.34% rise, over the last year Emmaus Life Sciences, Inc. has showed a 72.37% decrease.
EMMA net income for the last quarter is ‪67.00 K‬ USD, while the quarter before that showed ‪−1.48 M‬ USD of net income which accounts for 104.52% change. Track more Emmaus Life Sciences, Inc. financial stats to get the full picture.
No, EMMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EMMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Emmaus Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
EMMA reached its all-time high on Jan 3, 2008 with the price of 30593.8800 USD, and its all-time low was 0.0506 USD and was reached on Dec 20, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 55.00 employees. See our rating of the largest employees — is Emmaus Life Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Emmaus Life Sciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Emmaus Life Sciences, Inc. stock shows the sell signal. See more of Emmaus Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Emmaus Life Sciences, Inc. EBITDA is ‪805.00 K‬ USD, and current EBITDA margin is −35.52%. See more stats in Emmaus Life Sciences, Inc. financial statements.